Skip to content

Insider · CIK 0001023869

Merilee Raines

director

Files at WTS (WATTS WATER TECHNOLOGIES INC), OCUL (OCULAR THERAPEUTIX, INC), TMDX (TransMedics Group, Inc.). First filing -, latest -.

In brief

Merilee Raines files SEC Form 4 as director at WTS (WATTS WATER TECHNOLOGIES INC), and also at OCUL (OCULAR THERAPEUTIX, INC), TMDX (TransMedics Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Merilee Raines has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 8 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 3, 2026WTS
WATTS WATER TECHNOLOGIES INC
AGrant or award
Class A Common Stock
+456$0.00$021,670Aug 4, 2026
Jun 10, 2026OCUL
OCULAR THERAPEUTIX, INC
AGrant or award
Common Stock
+14,000$0.00$060,933Jun 12, 2026
Jun 10, 2026OCUL
OCULAR THERAPEUTIX, INC
AGrant or award
Stock Option (Right to Buy)derivative
+44,000$0.00$044,000Jun 12, 2026
May 20, 2026TMDX
TransMedics Group, Inc.
AGrant or award
Common Stock
+2,922$0.00$06,981May 22, 2026
Aug 5, 2025WTS
WATTS WATER TECHNOLOGIES INC
AGrant or award
Class A Common Stock
+516$0.00$021,214Aug 5, 2025
Jun 11, 2025OCUL
OCULAR THERAPEUTIX, INC
AGrant or award
Common Stock
+14,000$0.00$046,933Jun 13, 2025
Jun 11, 2025OCUL
OCULAR THERAPEUTIX, INC
AGrant or award
Stock Option (Right to Buy)derivative
+44,000$0.00$044,000Jun 13, 2025
May 22, 2025TMDX
TransMedics Group, Inc.
AGrant or award
Common Stock
+2,134$0.00$04,059May 23, 2025

Questions about Merilee Raines

Answered from the filings on this page, as of the latest one.

Is Merilee Raines buying or selling?

Merilee Raines has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Merilee Raines's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Merilee Raines has 0.

Where does Merilee Raines file Form 4?

Merilee Raines has filed Form 4 at WTS (WATTS WATER TECHNOLOGIES INC); OCUL (OCULAR THERAPEUTIX, INC); TMDX (TransMedics Group, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Merilee Raines: insider trades and track record | InsiderTell